Benefit of haploidentical hematopoietic stem cell transplantation for elderly patients with acute myeloid leukemia in first complete remission: A clinical observational study with in-depth time-dependent analysis
The efficacy of haploidentical hematopoietic stem cell transplantation (haplo-HSCT) in elderly patients with acute myeloid leukemia (AML) remains poorly defined. This study aimed to assess the survival benefit of haplo-HSCT among elderly AML patients compared to chemotherapy. AML patients more than 60...